Abstract:BackgroundIn cases where a glycolysis inhibitor is not utilized, blood cells in vitro can consume glucose. Although current guidelines suggest using citrate-buffered inhibitors or ice-water slurry to mitigate this, practical and financial constraints often hinder adherence to these recommendations. Our objective was to evaluate the difference in glucose concentration in our routine sample management by employing Citrate buffered/NaF, NaF, and Gel Barrier tubes.MethodsIn this study, we utilized Greiner FCmix citrate-buffered NaF and EDTA tubes (3 mL), Becton Dickinson NaF and EDTA tubes (4 mL), and Becton Dickinson SSTII Gel Barrier tubes (5 mL). Following venipuncture, the tubes were transferred to the laboratory and centrifuged within 30 minutes. Glucose levels of 46 patients' samples were measured using a Cobas 6000 system (c501) employing the Glucose Hexokinase method, which exhibits an intermediate coefficient of variation (CV) of approximately 1.5% and no significant bias, as confirmed by monitoring with Biorad EQAS.ResultsThe mean plasma glucose difference between Citrate-buffered tubes and NaF tube samples was 2.8 mg/dL with a 95% confidence interval (CI) ranging from 2.2 to 3.4 mg/dL (Mean: 0.16 mmol/L; CI: 0.12 - 0.19 mmol/L). The difference in paired samples of NaF plasma and Gel Barrier tubes serum glucose was 3.2 mg/dL with a CI of 2.5 - 3.9 mg/dL (Mean: 0.18 mmol/L; CI: 0.14 - 0.22 mmol/L). Lastly, the mean difference in Citrate-buffered plasma and serum Gel barrier tubes for 46 paired samples was 6.0 mg/dL with a CI of 5.2 - 6.7 mg/dL (Mean: 0.33 mmol/L; CI: 0.29 - 0.37 mmol/L).ConclusionsFollowing guidelines, Citrate-buffered/NaF tubes demonstrate efficacy as glucose stabilizers. When compared to NaF tubes alone within a 30-minute timeframe, the mean difference between the two types of tubes was 2.8 mg/dL. Although NaF tubes are no longer recommended for glucose testing in plasma, they still outperform gel barrier serum tubes by 3.2 mg/dL. Furthermore, compared to citrate/NaF Plasma, serum glucose levels were on average 6.0 mg/dL lower. The preanalytical sample stage poses a significant obstacle to its reliable use for diagnostic or monitoring purposes. Laboratories should consider transitioning to Citrate/NaF tubes, or employ mathematical corrections if utilizing gel separator tubes for glucose testing in their established preanalytical process.

The Study of 5 Levels Serum Glucose Standard Reference Materials

Evaluation of the precision and accuracy of the results from the 6 systems using 4 serum glucose analysis methods

Five different levels of secondary standard reference material of transaminase prepared with mixed freezing human serum

Investigation of precision and trueness of the glucose results from 15 measure systems in 4 domestic factories

Evaluation for serum glucose standardization in clinical laboratories of Southern China by consecutive 6 years proficiency testing based on JCTLM-recommended reference methods

Reproduction of reference method for serum glucose detection and comparison with routine glucose kits

[A Multi-Center Clinical Study of the Reference Value of Serum Glycated Albumin].

Reference Value Assay for a Hundred Healthy Persons'Serum Protein Conpoment by Automatic Rapid Electrophoresis Analyzer

Influence of serum preparation with separating gel vacuum tubes on the determination results and stability of blood glucose,complement C3 and neuron specific enolase

Establishment Of Normal Reference Ranges For Glycemic Variability In Chinese Subjects Using Continuous Glucose Monitoring

The Application of IFCC Reference Methods in Methodological Evaluation of Glycated Hemoglobin Measurement Systems

Reference values for continuous glucose monitoring in Chinese subjects.

Application of Five Frozen Human-Pooled Serum Samples Assigned by the International Federation of Clinical Chemistry and Laboratory Medicine Reference Procedure in a Traceability Investigation of Γ-Glutamyltransferase Catalytic Concentration Measurements in China

Evaluation of serum electrolytes measurement through the 6-year trueness verification program in China

Five days serum glucose stability at room-temperature in centrifuged fast-clotting serum tubes and the comparability with glucose in heparin-plasma and plasma containing citrate-stabilizer

A Comprehensive Stability Study of Glucose Concentrations Measured in Sodium Fluoride, Heparin and Serum Separator Tubes: A Cross-sectional Study

Reference Method Applied to Assigning Values for Calibrators in Serum Gamma-Glutamyltransferase Assays

Development and application of standard reference material in clinical electrolyte analysis

A-060 Assessing Glucose Stability: A Comparison of Citrate/NaF, NaF, and Gel Separator Vacuum Tubes in Routine Medical Laboratory Practice

Differences in the System Accuracy Acceptability of Four Types of Blood Glucose Monitoring Systems Against Five Different Standards

Traceability to a Primary Reference Measurement Procedure (ID-LCMS); A Key Step in Validating the Clinical Accuracy and Safety of Hospital Blood Glucose Monitoring Systems.